Health Care Reform

9 in 10 employers are concerned about high-cost drugs in the pipeline, with a similar number reporting concern about pharmacy cost trends overall.

The agency is exploring if the companies that broker drug purchases for hospitals, along with the drug distributors, are pushing the prices of generics so low that they've made it hard for manufacturers to maintain production.

The Centers for Medicare & Medicaid Services made "historic strides" in making health care and prescription drugs affordable, said Administrator Chiquita Brooks-LaSure, who updated stakeholders about CMS's accomplishments.

In January, the Biden administration pledged to increase public access to Medicare information to conduct research studies that can influence public health reforms, but this week the CMS announced a proposal to diminish access.

The amount an organization can absorb on behalf of their employees will depend on the market data, trends and individual company size.

PhRMA argued that the Inflation Reduction Act delegated too much power to HHS, however, the DOJ said the industry association lacked standing because it doesn't manufacture or sell prescription drugs.